
CAS Number98319-26-7
SynonymsProscar; Finasteride; Prostide; Finasterida; 17b-(N-tert-Butylcarbamoyl)-4-aza-5a-androst-1-en-3-one; (5a,17b)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; MK-906; Chibro-Proscar; Finastid; Propecia; Finpecia; Propecia (TN); Proscar (TN); MFCD00869737; Finasteridum
Molecular FormulaC23H36N2O2
Molecular Weight372.54
Purity98.00%
Density1.1±0.1 g/cm3
Boiling Point576.6±50.0 °C at 760 mmHg
Melting Point253 °C
AppearanceWhite to off-white crystalline powder
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 98319-26-7 |
| Catalog No. | 2A-9049494 |
| Chinese Name | 非那雄胺 |
| Synonyms | Proscar; Finasteride; Prostide; Finasterida; 17b-(N-tert-Butylcarbamoyl)-4-aza-5a-androst-1-en-3-one; (5a,17b)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; MK-906; Chibro-Proscar; Finastid; Propecia; Finpecia; Propecia (TN); Proscar (TN); MFCD00869737; Finasteridum |
| Molecular Formula | C23H36N2O2 |
| Molecular Weight | 372.54 |
| Purity | 98.00 |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 576.6±50.0 °C at 760 mmHg |
| Melting Point | 253 °C |
| Appearance | White to off-white crystalline powder |
| Water Solubility | insoluble |
| Storage Condition | Store airtight in a cool, dry warehouse. |
| Application | Finasteride is an orally active testosterone 5α-reductase inhibitor with a Ki of 10 nM. |
| HTC | 2937290090 |
| PubChem ID | 7847387 |
| SMILES | CC(C)(C)NC(=O)C1CCC2C3CCC4NC(=O)C=CC4(C)C3CCC12C |
| InChI | InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1 |
| InChI Key | DBEPLOCGEIEOCV-WSBQPABSSA-N |
| Hazard Symbols | T |
| Risk Codes | R22;R60;R61 |
| Safety Description | S36/37/39;S45;S53 |
| Bioactivity | Finasteride is an orally active testosterone 5-alpha-reductase inhibitor (Ki= 10 nM). Target: 5-alpha ReductaseApproved: 1992Finasteride, a synthetic 4-azasteroid antiandrogen compound, is a specific inhibitor of steroid Type II 5α-reductase, an intracellular enzyme that converts the androgen testosterone into 5α-dihydrotestosterone (DHT). Finasteride is used in the treatment of prostate cancer, benign prostatic hyperplasia, and androgenetic alopecia (male pattern baldness). In benign prostatic hyperplasia, finasteride inhibits 5alpha-reductase activity in epithelium for Ki of 10 nM, significantly lower than in stroma (Ki = 33nM) [1]. Related Catalog Signaling Pathways >> Metabolic Enzyme/Protease >> 5 alpha Reductase Research Areas >> Cancer References [1]. Weisser, H. and M. Krieg, In vitro inhibition of androstenedione 5alpha-reduction by finasteride in epithelium and stroma of human benign prostatic hyperplasia. J Steroid Biochem Mol Biol, 1998. 67(1): p. 49-55. Chemical & Physical Properties Density 1.1±0.1 g/cm3 Boiling Point 576.6±50.0 °C at 760 mmHg Melting Point 253 °C Molecular Formula C23H36N2O2 Molecular Weight 372.544 Flash Point 177.4±30.3 °C Exact Mass 372.277679 PSA 58.20000 LogP 3.24 Vapour Pressure 0.0±1.6 mmHg at 25°C Index of Refraction 1.524 InChIKey DBEPLOCGEIEOCV-WSBQPABSSA-N SMILES CC(C)(C)NC(=O)C1CCC2C3CCC4NC(=O)C=CC4(C)C3CCC12C Storage condition Store at RT Water Solubility insoluble |
| Use of | Finasteride is an orally active testosterone 5-alpha-reductase inhibitor (Ki= 10 nM). Target: 5-alpha ReductaseApproved: 1992Finasteride, a synthetic 4-azasteroid antiandrogen compound, is a specific inhibitor of steroid Type II 5α-reductase, an intracellular enzyme that converts the androgen testosterone into 5α-dihydrotestosterone (DHT). Finasteride is used in the treatment of prostate cancer, benign prostatic hyperplasia, and androgenetic alopecia (male pattern baldness). In benign prostatic hyperplasia, finasteride inhibits 5alpha-reductase activity in epithelium for Ki of 10 nM, significantly lower than in stroma (Ki = 33nM) [1]. Properties Articles106 Name finasteride Synonym More Synonyms Finasteride Biological Activity Description Finasteride is an orally active testosterone 5-alpha-reductase inhibitor (Ki= 10 nM). Target: 5-alpha ReductaseApproved: 1992Finasteride, a synthetic 4-azasteroid antiandrogen compound, is a specific inhibitor of steroid Type II 5α-reductase, an intracellular enzyme that converts the androgen testosterone into 5α-dihydrotestosterone (DHT). Finasteride is used in the treatment of prostate cancer, benign prostatic hyperplasia, and androgenetic alopecia (male pattern baldness). In benign prostatic hyperplasia, finasteride inhibits 5alpha-reductase activity in epithelium for Ki of 10 nM, significantly lower than in stroma (Ki = 33nM) [1]. Related Catalog Signaling Pathways >> Metabolic Enzyme/Protease >> 5 alpha Reductase Research Areas >> Cancer References [1]. Weisser, H. and M. Krieg, In vitro inhibition of androstenedione 5alpha-reduction by finasteride in epithelium and stroma of human benign prostatic hyperplasia. J Steroid Biochem Mol Biol, 1998. 67(1): p. 49-55. Chemical & Physical Properties Molecular Formula C23H36N2O2 Exact Mass 372.277679 PSA 58.20000 Index of Refraction 1.524 InChIKey DBEPLOCGEIEOCV-WSBQPABSSA-N Storage condition Store at RT Water Solubility insoluble |
| Transport Info | Product name: Purity: 98.0% |
| MSDS Transport Info | Module 14. Shipping information United Nations classification: inconsistent with United Nations classification standards UN number: not specified Finasteride Modification Number: 5 |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Triacetylganciclovir | 86357-14-4 | 2A-9049348 |
| Ciprofloxacin hydrochloride | 86483-48-9 | 2A-9049365 |
| Benazepril hydrochloride | 86541-74-4 | 2A-9049375 |
| Benazepril hydrochloride | 86541-77-7 | 2A-9049377 |
| Piroxicam pivalate | 87027-09-6 | 2A-9049425 |
| Interferon Alfa-2b | 98530-12-2 | 2A-9049515 |
| Teriparatide acetate hydrate | 99294-94-7 | 2A-9049603 |
| Venlafaxine hydrochloride | 99300-78-4 | 2A-9049607 |
| Domperidone maleate | 99497-03-7 | 2A-9049628 |
| Irinotecan hydrochloride | 100286-90-6 | 2A-9049700 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA